文献速递血管炎

彩色多普勒超声、FDG-PET/CT与MRI在疑似巨细胞动脉炎患者中诊断性能的直接比较

A direct comparison in diagnostic performance of CDUS, FDG-PET/CT and MRI in patients suspected of giant cell arteritis.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

该嵌套病例对照先导研究纳入23例巨细胞动脉炎(GCA)患者和19例疑似但未确诊GCA患者,在初始临床评估后5个工作日内完成彩色多普勒超声(CDUS)、全身FDG-PET/CT和头颅MRI。以风湿免疫科GCA专家随访6个月 blinded for imaging 的临床诊断为参考标准。CDUS敏感度最高(69.6%),三种影像学方法特异度均为100%,但置信区间重叠;FDG-PET/CT对孤立性颅外GCA均阴性(n=8),MRI对孤立性颅外GCA均阴性(n=4)。遵循EULAR推荐,CDUS可作为诊断GCA的首选检查;证据不足时需进一步检查并考虑GCA亚型。

要点

  • CDUS敏感度为69.6%(95%CI 50.4%-88.8%),FDG-PET/CT为52.2%(95%CI 31.4%-73.0%),MRI为56.5%(95%CI 35.8%-77.2%)。
  • CDUS、FDG-PET/CT和MRI的特异度均为100%。
  • FDG-PET/CT对孤立性颅外GCA均阴性(n=8),MRI对孤立性颅外GCA均阴性(n=4)。

核心结论

  • CDUS敏感度最高,三种影像学方法特异度均极好,但所有影像学方法的置信区间重叠。
  • 遵循EULAR推荐,CDUS可作为诊断GCA的首选检查;证据不足时需进一步检查并考虑GCA亚型。

研究设计与样本

  • 疑似GCA患者纳入嵌套病例对照先导研究,在初始临床评估后5个工作日内完成CDUS、全身FDG-PET/CT和头颅MRI。
  • 以风湿免疫科GCA领域经验丰富的风湿免疫科医生随访6个月、对影像学设盲的临床诊断作为参考标准。
  • 共纳入23例GCA患者和19例疑似但未确诊GCA患者,并进行了GCA亚型分层和不同风险分层组的影像学结果评估。

主要发现

  • CDUS敏感度为69.6%(95%CI 50.4%-88.8%),FDG-PET/CT为52.2%(95%CI 31.4%-73.0%),MRI为56.5%(95%CI 35.8%-77.2%)。
  • CDUS、FDG-PET/CT和MRI的特异度均为100%。
  • FDG-PET/CT对孤立性颅外GCA患者(n=8)均阴性,MRI对孤立性颅外GCA患者(n=4)均阴性。
  • 4例GCA患者CDUS结果为假阴性(n=2;中危和高危)或不确定(n=2;低危和中危),进一步影像学检查确认了诊断。

关键数值与推荐

  • CDUS敏感度69.6%(95%CI 50.4%-88.8%),FDG-PET/CT敏感度52.2%(95%CI 31.4%-73.0%),MRI敏感度56.5%(95%CI 35.8%-77.2%)。
  • CDUS、FDG-PET/CT和MRI特异度均为100%。
  • FDG-PET/CT对孤立性颅外GCA患者(n=8)均阴性,MRI对孤立性颅外GCA患者(n=4)均阴性。
  • 遵循EULAR推荐,CDUS可作为诊断GCA的首选检查;证据不足时需进一步检查并考虑GCA亚型。

临床怎么用

  • 遵循EULAR推荐,CDUS可作为诊断GCA的首选检查。
  • 当CDUS证据不足以诊断GCA时,需进一步检查并考虑GCA亚型。

局限性

  • 该研究为先导研究,样本量小(23例GCA患者和19例疑似但未确诊GCA患者)。
  • 所有影像学方法的置信区间重叠。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study directly compares the diagnostic performance of colour duplex ultrasound (CDUS), fluor-18-deoxyglucose positron emission tomography computed tomography (FDG-PET/CT) and magnetic resonance imaging (MRI) in patients suspected of giant cell arteritis (GCA). METHODS: Patients with suspected GCA were included in a nested-case control pilot study. CDUS, whole body FDG-PET/CT and cranial MRI were performed within 5 working days after initial clinical evaluation. Clinical diagnosis after six months follow-up by experienced rheumatologists in the field of GCA, blinded for imaging, was used as reference standard. Diagnostic performance of the imaging modalities was determined. Stratification for GCA subtype was performed and imaging results were evaluated in different risk stratification groups. RESULTS: In total, 23 patients with GCA and 19 patients suspected of but not diagnosed with GCA were included. Sensitivity was 69.6% (95%CI 50.4%-88.8%) for CDUS, 52.2% (95%CI 31.4%-73.0%) for FDG-PET/CT and 56.5% (95%CI 35.8%-77.2%) for MRI. Specificity was 100% for CDUS, FDG-PET/CT and MRI. FDG-PET/CT was negative for GCA in all isolated cranial GCA patients (n = 8), while MRI was negative in all isolated extracranial GCA patients (n = 4). In four GCA patients with false-negative (n = 2; intermediate and high risk) or inconclusive (n = 2; low and intermediate risk) CDUS results, further imaging confirmed diagnosis. CONCLUSIONS: Sensitivity of CDUS was highest, while specificity was excellent in all imaging modalities. Nevertheless, confidence intervals of all imaging modalities were overlapping. Following EULAR recommendations, CDUS can be used as a first test to diagnose GCA. With insufficient evidence for GCA, further testing considering GCA subtype is warranted.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. van Nieuwland M, Colin EM, Vermeer M, et al. A direct comparison in diagnostic performance of CDUS, FDG-PET/CT and MRI in patients suspected of giant cell arteritis. Rheumatology (Oxford). 2025. PMID: 38597882. doi:10.1093/rheumatology/keae171

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。